FDA Approves Merck’s DIFICID (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older Read more
Bionetix, ProQinase, and MercachemSyncom Announce a Joint Research Project from Target Identification to Clinical Study Read more
Join experts within supply and demand at Europe’s Only Parallel Trade Conference 2020 in London Read more
ATAI Life Sciences Announces Joint Venture with DemeRx to Develop Ibogaine For Opioid Use Disorder Read more